Literature DB >> 26819263

High-resolution myelin water imaging in post-mortem multiple sclerosis spinal cord: A case report.

Cornelia Laule1, Andrew Yung2, Vlady Pavolva3, Barry Bohnet2, Piotr Kozlowski4, Stanley A Hashimoto5, Stephen Yip6, David Kb Li7, Gr Wayne Moore8.   

Abstract

BACKGROUND: Loss of myelin in the spinal cord in multiple sclerosis (MS) is likely an important, and early, contributor to atrophy and associated disability. In vivo measurement of myelin is possible using myelin water fraction (MWF) imaging, but MWF has never been assessed in MS along the entire length of the spinal cord in vivo or in post-mortem tissue.
OBJECTIVE: To assess the feasibility of measuring the distribution of MWF along the entire length of the spinal cord in post-mortem MS tissue using high-field MRI.
METHODS: One formalin-fixed spinal cord from a female with secondary progressive MS (age: 78 years, disease duration: 25 years) was cut into 104 5-mm-thick cross sections along the entire length of the spinal cord from the cervico-medullary junction to the conus medullaris and imaged using a 64 echo T2 relaxation experiment at 7T.
RESULTS: Myelin water maps showed cord anatomy in superb detail, white matter demonstrating a higher MWF than the grey matter. Anatomical variation in myelin distribution along cervical, thoracic and lumbar regions was observed. Lesions demonstrated myelin loss.
CONCLUSION: Post-mortem myelin water imaging of formalin-fixed MS spinal cord is feasible.
© The Author(s), 2016.

Entities:  

Keywords:  MRI; Multiple sclerosis; demyelination; histology; myelin; spinal cord

Mesh:

Substances:

Year:  2016        PMID: 26819263     DOI: 10.1177/1352458515624559

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  9 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 2.  Inferring brain tissue composition and microstructure via MR relaxometry.

Authors:  Mark D Does
Journal:  Neuroimage       Date:  2018-01-02       Impact factor: 6.556

3.  Assessing structure and function of myelin in cervical spondylotic myelopathy: Evidence of demyelination.

Authors:  Hanwen Liu; Erin L MacMillian; Catherine R Jutzeler; Emil Ljungberg; Alex L MacKay; Shannon H Kolind; Burkhard Mädler; David K B Li; Marcel F Dvorak; Armin Curt; Cornelia Laule; John L K Kramer
Journal:  Neurology       Date:  2017-07-12       Impact factor: 9.910

Review 4.  Insights from Ultrahigh Field Imaging in Multiple Sclerosis.

Authors:  Matthew K Schindler; Pascal Sati; Daniel S Reich
Journal:  Neuroimaging Clin N Am       Date:  2017-01-26       Impact factor: 2.264

Review 5.  Imaging as an Outcome Measure in Multiple Sclerosis.

Authors:  Daniel Ontaneda; Robert J Fox
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

Review 6.  Advances in spinal cord imaging in multiple sclerosis.

Authors:  Marcello Moccia; Serena Ruggieri; Antonio Ianniello; Ahmed Toosy; Carlo Pozzilli; Olga Ciccarelli
Journal:  Ther Adv Neurol Disord       Date:  2019-04-22       Impact factor: 6.570

7.  Evaluating single-point quantitative magnetization transfer in the cervical spinal cord: Application to multiple sclerosis.

Authors:  Alex K Smith; Samantha By; Bailey D Lyttle; Richard D Dortch; Bailey A Box; Lydia J Mckeithan; Saakshi Thukral; Francesca Bagnato; Siddharama Pawate; Seth A Smith
Journal:  Neuroimage Clin       Date:  2017-07-14       Impact factor: 4.881

Review 8.  Magnetic Resonance of Myelin Water: An in vivo Marker for Myelin.

Authors:  Alex L MacKay; Cornelia Laule
Journal:  Brain Plast       Date:  2016-12-21

9.  Myelin Water Imaging Demonstrates Lower Brain Myelination in Children and Adolescents With Poor Reading Ability.

Authors:  Christian Beaulieu; Eugene Yip; Pauline B Low; Burkhard Mädler; Catherine A Lebel; Linda Siegel; Alex L Mackay; Cornelia Laule
Journal:  Front Hum Neurosci       Date:  2020-10-16       Impact factor: 3.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.